The narrative of direct primary care (DPC) and concierge medicine has long been dominated by the “entry story.” It is a tale of capital infusion, brand disruption, and the promise of a physician-patient relationship liberated from the administrative burdens of traditional fee-for-service medicine. From Goldman Sachs and Charlesbank’s involvement in MDVIP to the aggressive infrastructure building by firms like Revelstoke, Frontier, and the scaling models of Premise and Marathon Health, the influx of private equity (PE) has fundamentally reshaped the landscape.
The capital has arrived. The deal terms, while complex, are increasingly visible. Yet, the industry remains fixated on the initial acquisition, largely ignoring the far more critical chapter: the exit.
The Chronology of Private Equity Cycles
Private equity operates on a predictable, cyclical rhythm. Firms typically acquire physician practices or platforms with a three-to-eight-year investment horizon. The goal is simple: buy, scale, and sell. Research across various medical specialties—including dermatology, ophthalmology, and gastroenterology—shows that over 50% of practice acquisitions exit within just three years.
In the world of concierge and DPC, we are currently in the “scale” phase. Because these models are relatively young under institutional ownership, there is no comprehensive data set on their long-term exit outcomes. However, the underlying incentive structure remains immutable. Whether a practice generates revenue through procedural billing or membership-based cash flow, the mandate to scale remains the primary driver of exit value.
Consider the trajectory of Premise Health as a bellwether for the sector. OMERS Private Equity acquired the firm in 2018. By February 2026, the company had completed a major merger with Crossover Health. For the physicians, staff, and patients within that network, this cycle of ownership change occurred in the background—a "re-entry" that fundamentally altered the corporate structure without the input of those on the front lines of care.
The Mechanics of Multiple Arbitrage
At the heart of the PE thesis is a financial strategy known as “multiple arbitrage.” The process begins when a PE firm acquires a platform practice. It then proceeds to roll up smaller, independent practices that trade at lower valuation multiples, folding them into a single, larger network.
The brilliance of the strategy—from a purely financial perspective—is that the combined entity commands a higher valuation multiple simply because of its sheer size. Once a network is sufficiently scaled and recapitalized, it can command an exit price of 12 to 14 times EBITDA or more.
For the investor, the profit is harvested from the gap between the initial, lower-cost acquisition of individual units and the final, premium-priced sale of the consolidated enterprise. In this context, growth is not a byproduct of the clinical model; growth is the entire purpose of the PE thesis. The faster a platform can aggregate patients and providers, the higher the ultimate exit multiple.
The MDVIP Counterpoint: Network vs. Acquisition
Some proponents of private equity in healthcare point to MDVIP as proof that institutional ownership can foster stability. Having maintained its position under Goldman Sachs and Charlesbank since 2014, MDVIP boasts patient satisfaction scores consistently above 97%.
However, MDVIP’s longevity is a structural anomaly, not a deviation from the PE model. MDVIP operates as a network affiliation model. The firm does not own the clinics; it owns the brand, the infrastructure, and the referral engine. Physicians retain ownership of their practices. Because MDVIP is a license company rather than a direct owner of clinical assets, it does not face the same immediate pressure to consolidate and "flip" individual clinics.
Yet, even in the case of MDVIP, a long hold is not the absence of an exit; it is merely a delayed one. The license company remains an asset that, by its very nature, is designed for a future liquidity event.
Supporting Data: The Human Cost of the Exit
The most significant, yet rarely discussed, consequence of the PE exit cycle is physician attrition. Data suggests that the stability of a care model is inversely correlated with the frequency of ownership changes.
Studies indicate that physicians in PE-owned practices are 16.5 percentage points more likely to leave within two years of an exit event compared to those in non-PE environments. Two years post-sale, only 44% of physicians remain at their posts, whereas 60% of physicians in non-PE-backed practices remain with their original organizations.
The explanation is often found in the incentives. The financial packages that secure a physician’s commitment during the initial acquisition—often structured to encourage them to stay during the integration phase—frequently expire upon the exit. Once the PE firm cashes out, the remaining practices are often left with a hollowed-out balance sheet, burdened by debt obligations or reduced operational assets, creating an environment that encourages, or necessitates, physician departure.
The Diligence Question: Pricing the Risk
For current operators and investors, the "exit" is the most significant, yet least-priced, risk in the direct primary care market. If the primary value proposition of a concierge or DPC practice is the continuity of the physician-patient relationship, the degradation of that continuity during a turnover event is a catastrophic failure of the business model.
If an asset commands a premium multiple because of its patient loyalty, but the exit event systematically triggers a mass exodus of the physicians who built that loyalty, then the model is effectively cannibalizing its own value.
Key Implications for the Future:
- Contractual Transparency: Operators must demand clear, contractual guarantees regarding what happens to the clinical model and physician autonomy when the firm reaches its exit horizon.
- Operational Continuity: Investors should analyze the "exit-readiness" of their clinical staff. If a model relies on specific, high-touch physicians, an exit strategy that causes high turnover will inevitably lead to a valuation collapse.
- The Burden of Disruption: The market has yet to determine who absorbs the cost of the disruption caused by ownership changes. Currently, it is the patient and the physician. Until this risk is priced into the initial deal, the industry remains vulnerable to a cycle of instability.
Conclusion: The Unwritten Chapter
Private equity has provided the capital necessary to build the infrastructure that independent medicine desperately needed. For many physicians, the sale of their practice has provided a rational, tax-efficient exit strategy for their own careers.
However, we must move beyond the "entry story." We must stop viewing the initial acquisition as the final state of a medical practice. For the physicians, employers, and patients relying on these models, the most critical stage is the one that has not yet been addressed: the transition of ownership.
The long-term survival of the direct primary care model depends not on its ability to attract initial capital, but on its ability to withstand the inevitable exit of that capital. Until we can guarantee that the care model survives the financial mechanics of the exit, we are merely building a house of cards on a foundation of temporary, high-multiple growth. The market is waiting for the second act. The question is whether it will be one of consolidation, or one of collapse.
Disclaimer: This article is intended for informational purposes and does not constitute financial, legal, or medical advice. The author has no professional or financial relationship with the entities mentioned in this analysis.
